Literature DB >> 17804560

Gluten ataxia: passive transfer in a mouse model.

Sabrina Boscolo1, Alessandra Sarich, Andrea Lorenzon, Monica Passoni, Veronica Rui, Marco Stebel, Daniele Sblattero, Roberto Marzari, Marios Hadjivassiliou, Enrico Tongiorgi.   

Abstract

Gluten sensitivity is an autoimmune disease that usually causes intestinal atrophy resulting in a malabsorption syndrome known as celiac disease. However, gluten sensitivity may involve several organs and is often associated with extraintestinal manifestations. Typically, patients with celiac disease have circulating anti-tissue transglutaminase and anti-gliadin antibodies. When patients with gluten sensitivity are affected by other autoimmune diseases, other autoantibodies may arise like anti-epidermal transglutaminase in dermatitis herpetiformis, anti-thyroid peroxidase antibodies in thyroiditis, and anti-islet cells antibodies in type 1 diabetes. The most common neurological manifestation of gluten sensitivity is ataxia, the so-called gluten ataxia (GA). In patients with GA we have demonstrated that anti-gliadin and anti-tissue transglutaminase antibodies cross-react with neurons but that additional anti-neural antibodies are present. The aim of the present article is to review the knowledge on animal models of gluten sensitivity, as well as reviewing the role of anti-neural antibodies in GA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17804560     DOI: 10.1196/annals.1381.034

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  13 in total

Review 1.  Losing your nerves? Maybe it's the antibodies.

Authors:  Betty Diamond; Patricio T Huerta; Paola Mina-Osorio; Czeslawa Kowal; Bruce T Volpe
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

Review 2.  Immunologically mediated dementias.

Authors:  Michael H Rosenbloom; Sallie Smith; Gulden Akdal; Michael D Geschwind
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

3.  The Oslo definitions for coeliac disease and related terms.

Authors:  Jonas F Ludvigsson; Daniel A Leffler; Julio C Bai; Federico Biagi; Alessio Fasano; Peter H R Green; Marios Hadjivassiliou; Katri Kaukinen; Ciaran P Kelly; Jonathan N Leonard; Knut Erik Aslaksen Lundin; Joseph A Murray; David S Sanders; Marjorie M Walker; Fabiana Zingone; Carolina Ciacci
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

Review 4.  Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity.

Authors:  Jessica R Jackson; William W Eaton; Nicola G Cascella; Alessio Fasano; Deanna L Kelly
Journal:  Psychiatr Q       Date:  2012-03

5.  Anti transglutaminase antibodies cause ataxia in mice.

Authors:  Sabrina Boscolo; Andrea Lorenzon; Daniele Sblattero; Fiorella Florian; Marco Stebel; Roberto Marzari; Tarcisio Not; Daniel Aeschlimann; Alessandro Ventura; Marios Hadjivassiliou; Enrico Tongiorgi
Journal:  PLoS One       Date:  2010-03-15       Impact factor: 3.240

6.  Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis.

Authors:  E Myrsky; K Kaukinen; M Syrjänen; I R Korponay-Szabó; M Mäki; K Lindfors
Journal:  Clin Exp Immunol       Date:  2008-02-14       Impact factor: 4.330

7.  Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA.

Authors:  Essi Myrsky; Sergio Caja; Zsofi Simon-Vecsei; Ilma R Korponay-Szabo; Cristina Nadalutti; Russell Collighan; Alexandre Mongeot; Martin Griffin; Markku Mäki; Katri Kaukinen; Katri Lindfors
Journal:  Cell Mol Life Sci       Date:  2009-08-13       Impact factor: 9.261

Review 8.  Extraintestinal manifestations of coeliac disease.

Authors:  Daniel A Leffler; Peter H R Green; Alessio Fasano
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-08-11       Impact factor: 46.802

9.  Injection of celiac disease patient sera or immunoglobulins to mice reproduces a condition mimicking early developing celiac disease.

Authors:  Suvi Kalliokoski; Sergio Caja; Rafael Frias; Kaija Laurila; Outi Koskinen; Onni Niemelä; Markku Mäki; Katri Kaukinen; Ilma R Korponay-Szabó; Katri Lindfors
Journal:  J Mol Med (Berl)       Date:  2014-09-12       Impact factor: 4.599

10.  HLA-DR3-DQ2 mice do not develop ataxia in the presence of high titre anti-gliadin antibodies.

Authors:  Volga Tarlac; Louise Kelly; Nupur Nag; Judy Allen-Graham; Robert P Anderson; Elsdon Storey
Journal:  Cerebellum       Date:  2013-06       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.